Literature DB >> 4714113

Serum protein binding of erythromycin, lincomycin, and clindamycin.

R C Gordon, C Regamey, W M Kirby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4714113     DOI: 10.1002/jps.2600620704

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  17 in total

1.  The effect of cirrhosis on the disposition and elimination of clindamycin.

Authors:  G R Avant; S Schenker; R H Alford
Journal:  Am J Dig Dis       Date:  1975-03

Review 2.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

3.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

4.  Protein binding of clindamycin in sera of patients with AIDS.

Authors:  J F Flaherty; G Gatti; J White; J Bubp; M Borin; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 6.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

7.  Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.

Authors:  J F Flaherty; L C Rodondi; B J Guglielmo; J C Fleishaker; R J Townsend; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

8.  Clindamycin passage into human milk.

Authors:  B Stéen; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

9.  Should erythromycin dose be altered in haemodialysis patients?

Authors:  A Iliopoulou; K Downey; D M Chaput de Saintonge; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Serum and plasma concentrations of clindamycin following a single intramuscular injection of clindamycin phosphate in maintenance haemodialysis patients and normal subjects.

Authors:  A P Roberts; J B Eastwood; P E Gower; C M Fenton; J R Curtis
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.